Citadel Advisors’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.07M Buy
216,136
+119,854
+124% +$1.15M ﹤0.01% 2659
2025
Q1
$895K Buy
96,282
+40,695
+73% +$378K ﹤0.01% 3396
2024
Q4
$773K Buy
55,587
+31,635
+132% +$440K ﹤0.01% 3522
2024
Q3
$563K Buy
+23,952
New +$563K ﹤0.01% 3674
2024
Q2
Sell
-16,789
Closed -$275K 6836
2024
Q1
$275K Buy
+16,789
New +$275K ﹤0.01% 4490
2023
Q1
Sell
-26,717
Closed -$203K 6581
2022
Q4
$203K Sell
26,717
-13,902
-34% -$106K ﹤0.01% 4689
2022
Q3
$357K Sell
40,619
-34,226
-46% -$301K ﹤0.01% 4392
2022
Q2
$535K Sell
74,845
-3,464
-4% -$24.8K ﹤0.01% 4069
2022
Q1
$838K Sell
78,309
-4
-0% -$43 ﹤0.01% 3918
2021
Q4
$1.1M Buy
+78,313
New +$1.1M ﹤0.01% 3712